共 41 条
- [1] Allred D.C., Bustamante M.A., Daniel C.O., Immunocytochemical analysis of estrogen receptors in human breast carcinomas: Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance, Arch. Surg, 125, pp. 107-113, (1990)
- [2] Anne-Lise B., TP53 and breast cancer, Hum Mutat, 21, pp. 292-300, (2003)
- [3] Badwe R.A., Gangawal S., Mittra I., Desai P.B., Clinico-pathological features and prognosis of breast cancer in different religious communities in India, Indian J. Cancer, 27, pp. 220-228, (1990)
- [4] Baum M., The changing face of breast cancer--past, present and future perspectives, Breast Cancer Res. Treat, 75, (2002)
- [5] Bourn D., Carter S.A., Mason S., Gareth D., Evans R., Et al., Germline mutations in the neurofibromatosis type 2 tumour suppressor gene, Hum. Mol. Genet, 3, pp. 813-816, (1994)
- [6] Buyru N., Tigli H., Dalay N., P53 codon 72 polymorphism in breast cancer, Oncol. Rep, 10, pp. 711-714, (2003)
- [7] Chosdol K., Ahuja A., Rathore A., Anjan M., Syed H.M., Et al., Study of p53 codon 72 polymorphism in various ethnic groups of North India, Curr. Sci, 82, pp. 1253-1255, (2002)
- [8] Cutler W.B., Burki R.E., Genovesse E., Penn F., Zacher M.G., Et al., Breast cancer in postmenopausal women: What is the real risk?, Fertil Steril, 92, (2009)
- [9] Dako, Hoffman F., Hercep Test Interpretation Manual-Breast, (2002)
- [10] Dupont W.D., Page D.L., Risk factors for breast cancer in women with proliferative breast disease, N. Engl. J. Med, 312, pp. 146-151, (1985)